Content Type: Article

  • Transferable Restructuring – Opportunities and Risks for Investors

    Transferable Restructuring – Opportunities and Risks for Investors

    ARTICLE

    Transferable Restructuring – Opportunities and Risks for Investors

    September 13, 2021

    Read time: 2 min

    Key takeaways
    Overview

    The purchase of companies from insolvency offers considerable acquisition incentives for both strategic and institutional investors, not least due to the possibility of acquiring a company capable of being restructured at a favourable price. However, the opportunities also entail risks on the part of the acquirer. The article provides an overview of the regularly recurring issues in the context of distressed transactions, which should be taken into account in the negotiations of the company purchase agreement to be concluded. The article of Dr. Björn Biehl and Axel Jost is limited to the acquisition of an insolvent company in the course of insolvency proceedings by way of an asset deal.

    Source: Betriebs-Berater 37/2021

    In depth
    Authors
    More insights

  • German Real Estate Transfer Tax Reform

    ARTICLE

    German Real Estate Transfer Tax Reform

    September/October 2021

    Read time: 1 min

    Key takeaways
    Overview

    An article by Dr. Annette Keller and Dr. Isabella Denninger.

    In depth
    Authors

    Annette Keller

    Partner

    Munich

    More insights

  • New York State Employers Must Activate Exposure Prevention Plans Under the NY HERO Act

    New York State Employers Must Activate Exposure Prevention Plans Under the NY HERO Act

    ARTICLE / CLIENT ALERT

    New York State Employers Must Activate Exposure Prevention Plans Under the NY HERO Act

    September 13, 2021

    Read time: 6 min

    Key takeaways
    Overview

    On Monday, Sept. 6, 2021, Governor Kathy Hochul announced that the New York State Commissioner of Health had designated COVID-19 as a highly contagious communicable disease that presents a serious risk of harm to the public health under the New York Health and Essential Rights Act of 2021 (“HERO Act”). This designation requires all employers in New York State to implement and enforce their airborne infectious disease exposure prevention plans.

    SRZ has issued several client alerts on the HERO Act, which you can find here, here and here. The HERO Act required all employers to adopt an airborne infectious disease exposure prevention plan by Aug. 5, 2021. Employers, however, were not required to comply with, or enforce the terms of, their prevention plans until an airborne infectious disease was designated by the New York State Commissioner of Health as a highly contagious communicable disease. Until Sept. 6, 2021, no disease was designated.

    What Employers Need to Do Now

    Employers must “activate” their prevention plans and immediately begin compliance with their plans. To comply, employers should — if they have not already done so — distribute their prevention plans to each of their employees,[1] post their prevention plans in visible and prominent locations in their workplaces and conduct verbal trainings for their employees. Further, to implement their prevention plans, employers are required to enforce the prevention standards set forth in their plans, including, but not limited to, conducting regular cleanings, adhering to applicable guidance from the New York State Department of Health and the U.S. Centers for Disease Control and Prevention, and designating one or more employees to enforce compliance with their prevention plans. With respect to masks and social distancing, the HERO Act does not provide explicit requirements. Instead, the HERO Act states that employers’ prevention plans must set forth standards for masking and social distancing. The New York State Department of Labor (“DOL”) further explained that, at minimum, employers’ prevention plans must require physical distancing “be used, when possible, to keep employees at least six feet apart from other individuals,” and require employees to wear face masks “when physical distancing cannot be maintained.” The DOL’s model airborne infectious disease exposure prevention plan, which many employers adopted, provides that “face coverings and physical distancing should be used together whenever possible,” and “employees will wear face coverings throughout the workday to the greatest extent possible.” Therefore, the exact requirements for masks and physical distancing in the workplace depend on the terms of each employer’s prevention plan, but, at minimum, masks must be worn by all individuals in the workplace when physical distancing cannot be maintained, regardless of vaccination status. For more information on the HERO Act’s requirements, see SRZ’s previous client alerts (linked above) and the DOL’s prevention standards, the applicable industry model prevention plans, and the HERO Act’s Frequently Asked Questions.

    Employers should also be aware of the HERO Act’s multi-layered enforcement mechanism by the DOL, the New York State Attorney General and an employer’s own employees. The Commissioner of the DOL is entitled to investigate employers for alleged violations of the HERO Act. The Commissioner may assess a civil penalty of not less than $1,000 nor more than $10,000 for failure to abide by an adopted airborne infectious disease exposure prevention plan. There is a six-year statute of limitation for the DOL to assess this penalty. In addition, where a violation of this section is alleged to have occurred, the Commissioner or the New York State Attorney General may apply, on behalf of New York State, for an order enjoining or restraining the commission or continuance of the alleged unlawful acts.

    Employees are entitled to report violations of the HERO Act or their employer’s prevention plan to any state, local or federal government entity, public officer or elected official; report airborne infectious disease exposure concerns to any of the foregoing authorities or to the employer; and refuse to work where the employee “reasonably believes, in good faith, that such work exposes him or her, or other workers, or the public to an unreasonable risk of exposure to an airborne infectious disease due to the existence of working conditions that are inconsistent” with applicable laws or policies, including the prevention plan, provided the employer is notified “of the inconsistent working conditions and the employer failed to cure the conditions or the employer had or should have had reason to know about the inconsistent working conditions and maintained the inconsistent working conditions.” Employees are also entitled to bring a civil action for injunctive relief against their employer for violations of the prevention plan that created a substantial probability of serious physical harm or death. Pursuant to such civil action, courts are empowered to restrain violations of the prevention plan and to order all appropriate relief, including enjoining the conduct of the employer and awarding costs and reasonable attorneys’ fees to the employee. Before bringing such a civil action, employees must give their employer notice of the alleged violation and provide the employer with 30 days to cure the alleged violation, except where an employee alleges with particularity that the employer has demonstrated an unwillingness to cure a violation in bad faith. Employees have six months from the date they have knowledge of the alleged violation to bring such civil action.

    As always, if you have any specific questions about the HERO Act or how it impacts your organization, you should contact your SRZ attorney.

    Authored by Mark E. Brossman, Ronald E. Richman, Max Garfield, Scott A. Gold, Donna K. Lazarus and Abdulrahman Alwattar.


    [1] Employers must provide each employee with a copy of their exposure prevention plan in English or in the language identified as the primary language of such employee, if available. Currently, the New York State Department of Labor’s model plan is available in English and Spanish.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Mark E. Brossman

    Partner

    New York – 919 Third Avenue

    Ronald E. Richman

    Partner

    New York – 919 Third Avenue

    Max Garfield

    Partner

    New York – 919 Third Avenue

    Donna K. Lazarus

    Partner

    New York – 919 Third Avenue

    Abdulrahman Alwattar

    Associate

    New York – 919 Third Avenue

    More insights

  • New Remuneration Rules for Investment Firms

    ARTICLE

    New Remuneration Rules for Investment Firms

    September 11, 2021

    Read time: 1 min

    Key takeaways
    Overview

    Remuneration to be gender-neutral – multitude of requirements for variable components of salaries.

    In depth
    Authors
    More insights

  • New York Employers Must Activate HERO Act Workplace Safety Plans

    New York Employers Must Activate HERO Act Workplace Safety Plans

    ARTICLE / CLIENT ALERT

    New York Employers Must Activate HERO Act Workplace Safety Plans

    September 10, 2021

    Read time: 4 min

    Key takeaways
    Overview

    On September 6, 2021, New York Governor Kathy Hochul designated COVID-19 as a “highly contagious communicable disease that presents a serious risk of harm to the public health” under the New York Health and Essential Rights (HERO) Act. This designation means that all New York employers must activate the workplace safety plans that they developed under the HERO Act standards.

    In depth

    As McDermott previously reported, the workplace safety plan can be based on the model plan jointly developed by the New York State Department of Health (NYSDOH) and the New York State Department of Labor (NYSDOL). Employers can also develop their own plans, subject to certain minimum requirements discussed below.

    KEY EXPOSURE PREVENTION PLAN REQUIREMENTS

    Employers are required to establish a written prevention plan containing, among other things, the following key exposure controls:

    • Perform health screenings at the beginning of each workday and limit exposure to employees with any symptoms of an airborne infectious disease. Employers must also follow protocols for testing, isolation and quarantine before allowing employees to return to the workplace;
    • Implement physical distancing requirements to keep employees at least six feet apart;
    • Provide appropriate face coverings to employees and require face coverings when physical distancing cannot be maintained;
    • Provide either adequate handwashing facilities or hand sanitizing facilities/supplies to employees;
    • Implement an appropriate plan for cleaning and disinfecting frequently touched surfaces, shared tools, equipment, workspaces and common areas; and
    • Provide and require that employees use personal protective equipment (PPE), as required or recommended by the NYSDOH. The employer is responsible for ensuring that the PPE fits the employee and that the employee receives training on how to use the PPE. The employer must also ensure that PPE is provided, used and maintained in a sanitary and reliable condition.

    Upon request, employers must make the exposure prevention plan available to all employees, employee representatives, collective bargaining representatives, independent contractors, the NYSDOL and the NYSDOH.

    ADDITIONAL REQUIREMENTS FOR ALTERNATIVE PREVENTION PLANS

    If an employer chooses not to adopt the NYSDOL’s model prevention plan, it may instead draft its own alternative prevention plan. Employers choosing to do so must (1) meet the minimum standards of the model plan and (2) develop the plan in conjunction with the employees’ collective bargaining representative, or, if not applicable, then with “meaningful participation” of employees.

    NEXT STEPS

    Now that COVID-19 has received a HERO Act designation, employers must take the following steps:

    • Immediately review the worksite’s exposure prevention plan and update the plan, if necessary, to ensure that it incorporates current information, guidance and mandatory requirements issued by federal, state or local governments related to the infectious agent of concern;
    • Finalize and promptly activate the worksite exposure prevention plan;
    • Provide a verbal review of the plan with employees; and
    • Provide each employee with a copy of the exposure prevention plan in English or in the language identified as the primary language of such employees, if available. The plan must also be posted at the worksite and be accessible to employees during all work shifts.

    In addition to these action items, employers must provide employees with a copy of the written safety plan within 15 days of reopening after closure, or within 30 days of adopting the plan. Since Governor Hochul’s COVID-19 designation went into effect immediately, employers should aim to distribute the written safety plan by October 6, 2021. New employees must also be provided with a copy of the safety plan upon hire.

    COORDINATION WITH OSHA’S EMERGENCY TEMPORARY STANDARD

    The HERO Act’s requirements do not apply to employers covered by the US Occupational Safety and Health Administration’s (OSHA) Emergency Temporary Standard for the healthcare industry.

    MULTI-STATE EMPLOYERS

    The HERO Act’s requirements apply to all New York-based worksites, even if the employer is based outside of New York. It does not apply to employees who are telecommuting from their home, even if their home is located within New York State.

    NON-COMPLIANCE

    Employers who fail to comply with the HERO Act’s requirements may be subject to penalties of $50 per day of non-compliance, plus up to $10,000 for failure to abide by the HERO Act’s requirements.

    Authors

    Abigail M. Kagan

    Partner

    New York – One Vanderbilt Avenue

    More insights

  • Top Ten Investment Trends and Opportunities in the European Healthcare Market

    Top Ten Investment Trends and Opportunities in the European Healthcare Market

    ARTICLE / CLIENT ALERT

    Top Ten Investment Trends and Opportunities in the European Healthcare Market

    September 9, 2021

    Read time: 8 min

    Key takeaways
    Overview

    As the world enters a phase of the global pandemic marked by an increasing rate of vaccinations, investors are looking for global (particularly, European) healthcare market opportunities. With the emergence of certain investment trends, this article takes a look at what we have identified as the top ten, which have the potential to drive and shape the healthcare market over the short- and medium-term.

    In depth

    1) Expect to See More “Take Private” Transactions

    There is an increasing number of “take private” transactions being launched, especially in the United Kingdom. Since the start of 2021, market experts have seen nearly GBP 35bn of bids launched in the United Kingdom alone. This trend to “take private” is arguably because public markets are not pricing assets correctly. When compared to equivalent deals in the private arena, assets are relatively underpriced.

    2) More Infrastructure and Sovereign Wealth Funds (SWFs) Investing

    Infrastructure and SWFs are becoming increasingly active. These funds are now set up like sector teams at private equity funds (sometimes hiring from the same talent pool), so they provide a better insight into the market than was previously the case. Many infrastructure funds have also expanded their core segments beyond the traditional areas for infrastructure investment and see healthcare as “infrastructure plus.” As a result, more infrastructure funds closing deals in the healthcare space is expected, adding to an already highly competitive sector and helping to sustain higher prices for assets in this area.

    3) Continued High Prices in General with the Highest Prices Being Paid for Those Assets with the Greatest Growth Potential

    Though some pundits argue that investors are paying inflated prices for healthcare assets, others believe there is good price discipline and a sound rationale behind the current pricing. If you look carefully, you will see that there is a big differential between the various healthcare segments. Although healthcare earnings before interest, taxes, depreciation and amortization (EBITDA) multiples are averaging 14 to 17 times, market experts are seeing even higher multiples being paid in the healthcare tech area with EBITDA multiples of 20 times plus not uncommon. At the other end of the scale, healthcare assets in the care home sector are currently trading around the eight times EBITDA multiple. It is important for investors to understand the growth trajectory of those companies with the highest multiples and the structural shifts in global healthcare that are happening as a result of the pandemic. Understanding the trends makes pricing easier to understand—especially in cases where assets will be held long-term. The fact that there are some assets that are not trading because seller price expectations are too high underscores the case that investors continue to be disciplined and are only prepared to splash out where they can see the growth and a defensible competitive position.

    4) The Market Will Continue to be a Seller’s Market

    With the increasing number of entrants into the healthcare market highlighted above and each investor looking for the next big growth opportunity, market experts are also seeing an increasing number of preemptive bids for those assets with sellers driving aggressive deal terms. Preemptive buyers are likely to have been tracking an asset for some considerable time, which means they already understand and know the management ream as well as the growth trajectory of the business and its potential. Accordingly, a well-educated buyer can take an informed view on deal risks.

    Conversely, some processes where there are fewer participants are longer as buy-side parties conduct more substantive due diligence and look closely at the business plan to see if the target is sustainable and resilient.

    Against the background of COVID-19, investors are now asking, “How does this business model work?” and “If another hit comes, can it cope or be flexible?” In many cases, sellers will still decline to sell if their price expectations are not met and look to extract value in other ways, including through financing. They may also choose to revisit their own business plans and see how they can drive further growth and value before coming to the market again.

    5) There is New Awareness of Healthcare Vulnerabilities and More Government and Private Investment is Being Made in Healthcare Systems

    The needs of a global pandemic informed a reevaluation by governments about what needs to be done to set up a next-level healthcare system, including digitalization, supply chains for pharmaceuticals and supplies and telemedicine, and in the process, new investment opportunities have emerged in these and other areas. Governments appear to have recognised that they need to work with the private sector to deliver on this goal and improve healthcare for their populations and solve vulnerabilities that COVID-19 revealed. This presents real opportunities for investors and should further increase the size of the healthcare investment market.

    6) New Countries May Replicate Successful Franchise Models

    Market experts anticipate more opportunities to replicate some of the franchise and chain models that have become popular in the United Kingdom and other parts of Europe where the model is not yet established, such as Germany and (to a certain extent) France. This includes businesses in the dental, pharmacy, ophthalmology, wellness, veterinary and similar chain sectors.

    7) Compliance and Good Environmental, Social and Governance (ESG) is Earning a Premium

    Targets with a robust compliance system in place are earning premiums of up to 10%, particularly those that can show they flagged compliance issues in the past and rectified them. Although compliance has sometimes been seen as a pure cost centre for investors, it is now being looked upon as a positive value add. Having a robust compliance process in place assists sellers in achieving a smoother exit as fewer issues arise in this area and, therefore, does not give buy- side investors the opportunity to discount their bid price. Having good governance in place also helps drive valuations. Investors are demanding that the businesses they invest in have robust ESG policies because ESG factors are a key criterion in their investment decision-making.

    8) The Shift from Stationary to Ambulatory Continues

    There is a trend apart from stationary solutions that are more ambulatory, which is creating investment opportunities for businesses involved in every aspect of making that shift happen. For example, this would cover telephonic- and internet-based consultations, telemedicine, self-testing and the use of apps to gather data. This can lead to significant time and cost savings for both the consumer and the provider.

    9) There is New Momentum behind Globalization

    Healthcare was already globalizing but the pandemic served as an accelerant for this trend. The virtual trend allowed a realisation of the value and appeal of care in the home and has rapidly become more consumerised. At the same time, an entirely new world of consumer healthcare products began to gain real traction, such as wearable glucose monitors. People around the world are using the same apps and the same data. Both market shifts have resulted in patients accessing healthcare in new ways, with far more similarities worldwide than differences. As this new reality becomes the foundation from which healthcare solutions are developed, businesses are likely to expand faster geographically than they did historically.

    10) Public-Private Partnerships Present Meaningful Opportunities

    There has always been tension between the public sector provision of healthcare and the private sector’s involvement in it. Now, there’s a nearly universal commitment, effort and focus to make healthcare better, and there is no argument that the private sector has a significant part to play.

    This is partly based on the government’s limited liquidity (after all the pandemic schemes that have been put in place to keep their economies). With this backdrop, there has been no better time for the public and private sectors to work together to tackle the big health issues arising out of the pandemic, (e.g., the backlog of elective surgeries).

    The analysis presented in this article stems from McDermott Will & Emery’s HPE Europe 2021 virtual conference and key sessions examining the current challenges in healthcare investment and private equity. McDermott partners Tom Whelan and Hamid Yunis served as session moderators and were joined by fellow McDermott partner Dr. Nadine Hartung, as well as healthcare industry experts Dr. Ali Parsa, CEO & Founder of Babylon Health; Henry Elphick of the European Healthcare Private Equity Association (EHCPEA); Karl Geisel of Five Arrows Principal Investments; Rohin Jain of HIG Capital; Sylvester Oppong of EY and Dr. Michelle Tempest of Candesic Limited.

    Authors
    More insights

  • Shortcut to the Stock Exchange: Opportunities and Design Options for Going Public via SPAC

    ARTICLE

    Shortcut to the Stock Exchange: Opportunities and Design Options for Going Public via SPAC

    September 6, 2021

    Read time: 2 min

    Key takeaways
    Overview

    Special purpose acquisition companies (SPACs) are enjoying rapidly growing popularity as more and more companies choose to go public via this vehicle. SPACs have long flourished in the United States, and now they are also going public in Germany and throughout Europe. But how can an initial public offering (IPO) via SPAC be achieved? What opportunities and design options are there for going public via SPAC?

    In depth
    Authors

    Dr. Philipp Grenzebach

    Partner

    Düsseldorf, Frankfurt

    More insights

  • Clean Exit – Wishful Thinking or Buyer’s Nightmare? Recent Market Trends and Practical Recommendations for Sellers and Buyers

    ARTICLE

    Clean Exit – Wishful Thinking or Buyer’s Nightmare? Recent Market Trends and Practical Recommendations for Sellers and Buyers

    September 6, 2021

    Read time: 2 min

    Key takeaways
    Overview

    Due to sellers’ continuing strong negotiating position in M&A transactions in many sectors, seller-friendly purchase agreements have become more common, particularly in auction processes and also in the German market. This trend is associated with an allocation of risks from the seller to the buyer, which is conceptually referred to as a clean exit for the seller. But there is a lot more to the story, there are pros and cons to weigh out. What are the current market trends? What do sellers and buyers need to take into consideration?

    In depth
    Authors
    More insights

  • Health M&A during Covid-19 and Beyond

    ARTICLE

    Health M&A during Covid-19 and Beyond

    September 6, 2021

    Read time: 2 min

    Key takeaways
    Overview

    After the Covid-19 pandemic reached Europe in early 2020, the German healthcare market went into a brief shock paralysis along with the entire country. Several ongoing or planned transactions in the healthcare sector were abruptly cancelled or postponed. After only two or three months, this changed again dramatically, as stakeholders quickly realized that answers to the pandemic could be found in healthcare – and for investors, in the healthcare market. A primary focus was on testing, and clinical labs were suddenly more on the radar than possibly ever before. How did Health M&A develop during Covid-19 and what does the future hold?

    In depth
    Authors
    More insights

  • Supervisory Board Service and VAT: Will Change in Jurisprudence Impact PE Advisory Boards?

    Supervisory Board Service and VAT: Will Change in Jurisprudence Impact PE Advisory Boards?

    ARTICLE

    Supervisory Board Service and VAT: Will Change in Jurisprudence Impact PE Advisory Boards?

    September 6, 2021

    Read time: 2 min

    Key takeaways
    Overview

    A supervisory board is a body that is entrusted by the company’s articles of association with supervision of the company’s management. Yet, under German tax law, service as a member of a supervisory board is regarded as self-employed activity for income tax purposes, in addition to any income generated from self-employed/independent activities. Will change in jurisprudence impact PE advisory boards?

    In depth
    Authors

    Marcus Fischer

    Counsel

    Frankfurt

    More insights